Your session is about to expire
← Back to Search
Educational Mobile App for Breast Cancer Screening
N/A
Waitlist Available
Led By SOONHEE ROH, PhD
Research Sponsored by University of South Dakota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Women who are aged 40 to 70 years
Women who are willing to use their own mobile phone, iPad, tablets, and computers, or a mobile phone borrowed from the research team for the wMammogram intervention.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 month
Awards & highlights
Study Summary
This trial aims to develop and test the feasibility and effectiveness of a mobile web app intervention to increase mammogram rates among American Indian women in rural areas.
Who is the study for?
This trial is for self-identified American Indian women aged 40 to 70 years from the YST in South Dakota who haven't had a mammogram in the past two years. Participants must be willing to use their own mobile devices or one provided by researchers for the intervention.Check my eligibility
What is being tested?
The study tests a culturally tailored educational mobile app, wMammogram, designed to increase breast cancer screening rates among participants compared with those receiving printed educational materials. It includes an initial survey, a week of using the app, and follow-up surveys after one week and six months.See study design
What are the potential side effects?
Since this trial involves an educational intervention rather than medication or medical procedures, traditional physical side effects are not expected. However, there may be emotional or psychological responses to content about breast cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman aged between 40 and 70.
Select...
I am willing to use a mobile device or computer for the wMammogram study.
Select...
I haven't had a mammogram in the last two years.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 6 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mammography receipt
Secondary outcome measures
Breast cancer knowledge
Cultural attitudes
Health beliefs
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants are randomized to interventional arm which is seven-day intervention that requires them to download mobile app to complete educational courses each day. There are pre and post tests to complete and a follow up focus group six month after intervention. The intervention encourages education on mammogram needs.
Group II: ControlActive Control1 Intervention
Participants are randomized to control arm where they are give an education brochure. There are pre and post tests to complete.
Find a Location
Who is running the clinical trial?
University of North DakotaOTHER
15 Previous Clinical Trials
1,085 Total Patients Enrolled
2 Trials studying Breast Cancer
136 Patients Enrolled for Breast Cancer
University of South DakotaLead Sponsor
13 Previous Clinical Trials
1,758 Total Patients Enrolled
SOONHEE ROH, PhDPrincipal InvestigatorUniversity of South Dakota
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a woman aged between 40 and 70.I am willing to use a mobile device or computer for the wMammogram study.I had a mammogram within the last year.I haven't had a mammogram in the last two years.I'm sorry, I'm not familiar with the acronym "AI women of the YST in SD." Can you provide more context or clarify the acronym?I am a woman under 40 or over 70 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger